EPISODE · Oct 27, 2022 · 29 MIN
Part 2: Clinical Trials: Bringing Research to Life
from Science Will Win · host Pfizer
In part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials?Featured Guests:Laurie, Breast Cancer Clinical Trial ParticipantDr. Edith Mitchell, Medical Oncologist, Thomas Jefferson UniversityJulia Perkins Smith, Global Clinical Lead, PfizerJamil Rivers, CEO, Chrysalis InitiativeAdditional Resources:pfizerclinicaltrials.com/oncologypfizerclinicaltrials.compfizerestudiosclinicos.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
In part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials?
Ready to play
Part 2: Clinical Trials: Bringing Research to Life
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.